Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration

Cornea-Habert, 1999, Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat, J. Comp. Neurol., 409, 187, 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P

Dean, 1999, Changes in serotonin2A and GABAA receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex, J. Neurochem., 72, 1593, 10.1046/j.1471-4159.1999.721593.x

Hamada, 1998, Localization of 5-HT2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken, Mol. Brain Res., 54, 199, 10.1016/S0169-328X(97)00322-7

Ikemoto, 1997, Demonstration of l-dopa decarboxylating neurons specific to human striatum, Neurosci. Lett., 232, 111, 10.1016/S0304-3940(97)00587-9

Ikemoto, 1998, A dopamine-synthesizing cell group demonstrated in the human basal forebrain by dual labeling immunohistochemical technique of tyrosine hydroxylase and aromatic l-amino acid decarboxylase, Neurosci. Lett., 243, 129, 10.1016/S0304-3940(98)00103-7

Ikemoto, 1998, Do all of human midbrain tyrosine hydroxylase neurons synthesize dopamine?, Brain Res., 805, 255, 10.1016/S0006-8993(98)00661-1

Ikemoto, 1999, Cholinergic neurons with monoamine oxidase type B (MAOB)-activity in the laterodorsal tegmental nucleus of the mouse, Neurosci. Lett., 271, 53, 10.1016/S0304-3940(99)00512-1

Jansson, 1998, On the relationship of 5-hydroxytryptamine neurons to 5-hydroxytryptamine 2A receptor-immunoreactive neuronal processes in the brain stem of rats. A double immunolabelling analysis, NeuroReport, 9, 2505, 10.1097/00001756-199808030-00015

Kapur, 1996, Serotonin–dopamine interaction and its relevance to schizophrenia, Am. J. Psychiatry, 153, 466, 10.1176/ajp.153.4.466

Kelland, 1990, Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons, J. Pharmacol. Exp. Ther., 253, 803

Kung, 1998, Immunocytochemical localization of tyrosine hydroxylase in the human striatum: a postmortem ultrastructural study, J. Comp. Neurol., 390, 52, 10.1002/(SICI)1096-9861(19980105)390:1<52::AID-CNE5>3.0.CO;2-P

Nagatsu, 1977, Immunofluorescent studies on tyrosine hydroxylase: application for its axoplasmatic transport, Acta Histochem. Cytochem., 10, 494, 10.1267/ahc.10.494

Nakamura, 1993, A subpopulation of mouse striatal cholinergic neurons show monoamine oxidase activity, Neurosci. Lett., 161, 141, 10.1016/0304-3940(93)90279-T

R. Nieuwenhuys, J. Voogd, Chr. van Huijzen, The Human Central Nervous System, A Synopsis and Atlas, Springer-Verlag, Berlin, 1979.

Nyberg, 1999, Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients, Am. J. Psychiatry, 156, 869, 10.1176/ajp.156.6.869

O'Neill, 1999, 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB, Pharmacol. Biochem. Behav., 63, 237, 10.1016/S0091-3057(98)00240-8

Pazos, 1987, Serotonin receptors in the human brain: IV. Autoradiographic mapping of serotonin-2 receptors, Neuroscience, 21, 123, 10.1016/0306-4522(87)90327-7

Ugedo, 1989, Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition, Psychopharmacology, 98, 45, 10.1007/BF00442004

Wu, 1998, Development and characterization of monoclonal antibodies specific to the serotonin 5-HT2A receptor, J. Histochem. Cytochem., 46, 811, 10.1177/002215549804600704